Abstract
PD0332991 (palbociclib/Ibrance((R))) is a cyclin-dependent kinase (CDK)4/6 inhibitor that has recently been approved for the treatment of estrogen rec......
小提示:本篇文献需要登录阅读全文,点击跳转登录